Colorectal cancer (CRC) screening is underutilized. To effect change, we must understand reasons for underuse at multiple levels of the health-care system. We evaluated patient, provider, and clinic factors that predict variation in CRC screening among primary-care clinics and primary-care providers (PCPs).
INTRODUCTION
Colorectal cancer (CRC) is the second leading cause of cancerrelated deaths for both men and women in the United States, claiming nearly 50,000 lives each year ( 1 ) . If optimally employed, available CRC screening modalities have the potential to significantly reduce CRC mortality ( 2 -10 ) . Screening is underutilized despite the variety of screening tools available, existing evidence on the eff ectiveness of these tools, and recommendations from multiple professional societies supporting CRC screening. A recent NIH Conference, " Enhancing Use and Quality of Colorectal Cancer Screening " , highlighted the importance of monitoring trends in CRC screening in order to better understand factors leading to underuse of this life-saving preventive service ( 11 ) . In addition, a current National Cancer Institute priority calls for further understanding of the factors that infl uence cancer prevention at each level of the health-care system ( 12, 13 ) .
CRC screening is a complex process involving multiple factors at multiple levels of the health-care system (i.e., clinic, provider, and patient). Existing literature focuses on predictors of CRC screening at the patient level with few studies addressing potential provider COLON/SMALL BOWEL Weiss et al.
factors ( 14 ) . Minimal data on the combination of patient, provider, and clinic factors that infl uence CRC screening rates exist. Such information is important because it can direct interventions to improve CRC screening at each level of the health-care system.
Th e aim of this study is to evaluate patient-, provider-, and cliniclevel factors that predict variation in CRC screening practices among primary-care clinics and primary-care providers (PCPs). To address these objectives, we use data from the Wisconsin Collaborative for Healthcare Quality (WCHQ). Th rough WCHQ, Wisconsin is the only state that publicly reports CRC screening at the health system level for all patients and all payers ( 15 ) . WCHQ is a voluntary, state-wide partnership of health-care organizations ( 16 ) that has been tracking CRC screening rates across multiple health systems since 2005.
METHODS

Study setting
We retrospectively analyzed CRC screening practices within UW Health, a long-standing WCHQ participant. UW Health is one of the 12 largest multispecialty physician groups in the United States, comprised of both multispecialty and community-based primarycare clinics that provide 1.7 million ambulatory visits per year. Primary care is delivered by over 300 providers in more than 40 primary-care clinic sites. Primary-care clinics are owned and managed by either the hospital or the physician group practice. Diff erences in ownership and management are associated with diff erent clinic infrastructure and populations served. We report on 19 primary-care clinics with > 300 patients eligible for CRC screening and 97 PCPs with > 100 eligible patients in their panels. Th e use of these thresholds confers stability of results from clinics and providers by excluding those with small numbers of eligible patients ( 17 ) . Th e Institutional Review Board at the University of WisconsinMadison approved this study with a waiver of consent.
Identifi cation of screen-eligible population
Electronic medical record (EMR) data were used to identify the potential pool of eligible patients in 2009 using the WCHQ defi nition created for public reporting, which is based on the Healthcare Eff ectiveness Data and Information Set metrics ( 15, 18 ) . Adults aged 50 -75 years were included if they were " currently managed " by the physician group. Patients were considered " currently managed " if they had at least two primary-care offi ce visits in an outpatient, non-urgent care setting within the previous 36 months, with at least 1 of those visits in the prior 24 months. For example, to be included as currently managed for 2009, the patient needed to have at least two visits in the combined years 2007, 2008, and 2009 , with at least one being in 2008 or 2009. Th is defi nition ensures that patients who have a single visit to a clinic but seek care permanently elsewhere are not included in our screening measures ( 19 ) . We identifi ed primary-care clinics and providers by specialty (Internal Medicine and Family Medicine). Patients were excluded if they had a history of a total colectomy based on ICD-9 codes (45.8 × ) and CPT codes (44150, 44151, 44155 -44158, 44210 -44212, and 44799).
Identifi cation of CRC screening completion
From the pool of patients eligible for CRC screening, completion of screening was determined by (a) fecal occult blood test (FOBT) in the prior 12 months, (b) fl exible sigmoidoscopy, double contrast barium enema, or computed tomographic (CT) colonography in the past 5 years ( 20 ) , or (c) optical colonoscopy in the prior 10 years. Th is was obtained through review of EMR data using the codes identifi ed by WCHQ, which are consistent with the Healthcare Eff ectiveness Data and Information Set metrics (see Supplementary Table S1 online).
All PCPs have open access to optical and CT colonography in our system, and most local third party payers cover CT colonography as a CRC screening modality ( 21 ) .
Explanatory variables
We examined the relationship between the likelihood of a patient completing a CRC screening test and several predictors at the patient, PCP, and clinic levels of our health-care system. Patient and clinic predictors obtained from the EMR included age, gender, race / ethnicity (White and Non-White), marital status, primary language (English and Non-English), comorbidities (congestive heart failure, diabetes mellitus, and hypertension), insurance coverage (Commercial, Medicare, Medicaid, or Uninsured), clinic management (hospital-owned vs. physician-owned), and the number of providers within the clinic that care for patients who are eligible for CRC screening. A health-care resource utilization score was assigned to each patient through the use of Ambulatory Care Groups ( 22, 23 ) on the basis of outpatient and inpatient diagnoses from the 12 months before 2009. Th is score is based on evidence that certain groups of medical conditions have similar health-care resource utilization. Clinic distance to the nearest optical colonoscopy facility was calculated using geographical soft ware.
PCP predictors obtained from the EMR included gender, specialty (Internal Medicine and Family Medicine), years in practice, and size of their patient panel eligible for CRC screening. PCP perceptions of major barriers to CRC screening at the patient, provider, and system levels were measured by survey. We administered a survey to all PCPs within UW Health in February 2010 with a 70 % response rate ( N = 226 / 322) to examine their CRC screening beliefs and practices in the previous year. Th e survey was based on the National Cancer Institute Survey of Colorectal Cancer Screening Practices developed in collaboration with the CDC and Centers for Medicare and Medicaid Services, and has been used extensively in prior research ( 24 -27 ) . Survey items were organized into four sections: (1) cancer screening beliefs and practices -perceived value of CRC screening and perceptions of their own (and their peers ' ) CRC screening practice; (2) attitudes toward CRC screening -importance of perceived barriers to CRC screening at the patient, provider, and system levels; (3) CRC screening modalities -recommendations for and use of each CRC screening method; and (4) provider characteristics -short validated 10-item personality inventory ( 28 ) . Survey items were adapted to address issues relevant to UW Health (such as the option to choose CT colonography).
Th e survey question included in this analysis had the following stem: " In the US today, many adults over the age of 50 are not screened for colorectal cancer. In your opinion, how important are each of the following as potential barriers to colorectal cancer screening? " Respondents could rank the following potential barriers as a " major barrier " , " minor barrier " , or " not a barrier " . Patient barriers included fear of fi nding cancer, belief that screening is not eff ective, embarrassment or anxiety about screening tests, unaware of screening or does not perceive CRC as a serious health threat, fear of an invasive test, and concern about tolerating prep. Provider barriers included not enough time in clinic to discuss screening and the perception that many PCPs do not actively recommend screening to their patients. System barriers included long wait times between ordering and scheduling a test, fi nancial costs to the patient, shortage of trained providers to conduct screening tests, and lack of a systematic way to identify patients eligible for screening. Responses were counted as 1 for indicating a " major barrier " and 0 for indicating " minor / not a barrier " .
Statistical analysis
CRC screening rates for individual primary-care clinics and individual PCPs within clinics are presented for the year 2009. Th e frequency of diff erent CRC screening modalities is described. We compared the frequency of all patient, provider, and clinic variables for the screened and unscreened patient population by using χ 2 tests for categorical variables and two-way analysis of variance tests for continuous variables. Multivariate logistic regression with robust estimation of the s.e. ' s and clustering at the clinic level was performed with the logit procedure in Stata to obtain odds ratios and 95 % confi dence intervals for the patient, provider, and clinic predictors of our primary outcome, completion of CRC screening at the patient level. All variables listed in Table 3 were included in the multivariate logistic regression model. Analyses were carried out with Stata 12.0 (StataCorp, College Station, TX) and SAS 9.3 (SAS Institute, Cary, NC) soft ware. All tests of signifi cance used two-sided P values at the P < 0.05 level.
RESULTS
CRC screening modalities
Th e most common CRC screening modality in our health-care system was optical colonoscopy (86 % ). CT colonography (8 % ) and FOBT (4 % ) were used infrequently, and fl exible sigmoidoscopy and double contrast barium enema almost never.
Overall sample characteristics
Over 34,000 patients were identifi ed as eligible for CRC screening in 2009 according to the methodology previously described. Th e majority of patients were between 50 and 60 years of age, 58 % were women, 93 % were white, most were married, 94 % speak English as their primary language, and more than two-thirds had commercial insurance coverage ( Table 1 ). For the 97 PCPs, 49 % were female, over half practice in Internal Medicine (59 % ) with 41 % in Family Medicine, > 50 % have been in practice for more than 20 years, and the average number of patients in a provider ' s panel that are eligible for CRC screening is over 480. On average, PCPs perceived more major barriers to CRC screening to exist at the patient level compared with the provider and system levels. Two-thirds of the primary-care clinics were physician-owned (as compared with hospital-owned), the average number of providers caring for patients eligible for CRC screening in each clinic was 10, and the average distance of the clinics to the nearest optical colonoscopy facility was 6.5 miles.
Sample characteristics by screening status (screened vs. not screened)
All patients were assigned to PCPs using the plurality provider algorithm described by Pham et al. ( 29 ) . PCPs were assigned to clinics by the clinic at which the provider billed most of his or her Evaluation & Management visits during the year. Seventy-one percentage of patients ( N = 24,372) completed their CRC screening and 29 % ( N = 9,947) were not screened ( Table 2 ). Signifi cant diff erences were observed between the screened and not screened patients in patient, provider, and clinic variables. Although statistically signifi cant owing to the large sample size, some of these diff erences were not clinically signifi cant (e.g., patient race).
Patient variables:
Patients who completed screening were older (48 % of screened patients were between 60 and 75 years old vs. 45 % of patients who were not screened, P < 0.001), more oft en white (94 vs. 92 % , P < 0.001), more oft en married (74 vs. 65 % , P < 0.001), spoke English as a primary language (95 vs. 91 % , P < 0.001), had more commercial insurance coverage (74 vs. 68 % , P < 0.001), and more health-care resource utilization (Ambulatory Care Group Resource Utilization Score of 0.6 vs. 0.5, P < 0.001).
Provider variables:
Patients who were screened were more likely to be seen by PCPs who have been in practice longer (87 % of screened patients are seen by PCPs who have been in practice for ≥ 10 years vs. 83 % of patients who were not screened, P < 0.001), are female (50 vs. 48 % , P = 0.01), practice Internal Medicine (63 vs. 50 % , P < 0.001), and have larger panels of patients eligible for CRC screening (500 vs. 460, P < 0.001). Patients who completed screening were also seen by PCPs who perceived more major barriers to CRC screening at the patient and system levels (2.5 vs. 2.3, P < 0.001 and 1.8 vs. 1.6, P < 0.001, respectively).
Clinic variables:
Patients who were screened were signifi cantly more likely to receive their primary care at a hospital-owned clinic (36 vs. 26 % , P < 0.001) and a clinic that is closer to the nearest optical colonoscopy center (6.2 vs. 7.2 miles, P < 0.001).
CRC screening rates among primary-care clinics
Variation in CRC screening rates was seen across 19 primary-care clinics within the health system ( Figure 1 ). CRC screening rates by primary-care clinic ranged from 51 to 80 % .
CRC screening rates among PCPs
Variation in CRC screening rates also existed among PCPs across the system and within each clinic ( Figure 2 ). CRC screening rates by PCP ranged from 51 -82 % in the clinic with the largest spread, compared with a range of 60 -64 % in the clinic with the smallest spread.
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Predictors of CRC screening variation
Logistic regression with clustering on clinics, controlling for all patient, provider, and clinic variables, revealed signifi cant predictors of CRC screening variation at each level. Signifi cant patient-level predictors for completing screening were increasing age, White race, being married, primarily English speaking, having commercial insurance coverage, not having congestive heart failure or diabetes, and utilizing more health-care resources ( Table 3 ) . Th e only signifi cant provider-level predictor of CRC screening completion aft er controlling for multiple patient and clinic factors was increasing panel size of patients eligible for CRC screening. Clinic-level predictors of CRC screening completion were that the clinic was hospital-owned rather than physician-owned, and shorter distance to the nearest optical colonoscopy center.
DISCUSSION
Th e overall CRC screening rate in our health-care system is relatively high (71 % in 2009). Even in this setting, we found variation in screening rates among primary-care clinics (51 -80 % ) and among providers within a clinic (51 -82 % in the clinic with the largest spread). We also show that predictors of this variation exist at the patient (age, race, marital status, primary language, insurance coverage, comorbidities, and health-care resource utilization), provider (panel size eligible for CRC screening), and clinic (physician-vs. hospital-owned, and distance to nearest optical colonoscopy center) levels. In response to the NIH call to monitor trends in the use of CRC screening to better understand factors leading to underuse of this preventive service ( 11 ), our study shows that examination needs to occur at all levels of the healthcare system and confi rms the National Cancer Institute priority for multilevel analysis and multilevel interventions to improve the cancer care continuum ( 12, 13, 30 ) .
Previous studies have shown that patient characteristics associated with higher CRC screening rates include increasing age, gender, marriage, white race, insurance coverage, and presence of comorbidities ( 31 -37 ). Our study shows age is a signifi cant predictor of CRC screening. In an earlier model, the relationship between age and CRC screening was determined to be nonlinear and might represent competing health demands with increasing age ( 38 -40 ) . We also confi rmed prior fi ndings of the relationship between 
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Gender, %
Female 58
Race, %
White 93
Marital status, %
Married 71
Language, %
English (as primary language) 94
Insurance, % In contrast to some previous reports, we found no signifi cant association between gender and CRC screening in our multivariate model. Christman et al. ( 37 ) reported that patients with more chronic illnesses, as measured by the Charlson comorbidity score, were more likely to be screened for CRC. Similarly, we found that patients with higher health-care resource utilization by Ambulatory Care Group scores were more likely to be screened. Th is score is based on evidence that certain groups of medical conditions have similar health-care resource utilization and our fi ndings are consistent with the overall idea that patients who have more contact with the health-care system are more likely to receive preventive services. However, we decided to further examine the relationship between a few specifi c comorbidities and CRC screening, and found that patients with congestive heart failure were signifi cantly less likely to complete CRC screening, which probably refl ects the overwhelming use of optical colonoscopy, which uses sedation, in our system. We also found that patients with diabetes were significantly less likely to be screened, which may represent the eff ect of competing demands in patient care. Current literature on PCP factors infl uencing CRC screening focuses on the physician recommendation for screening ( 25, 41, 42 ) . Little data exist on other PCP characteristics such as demographics and practice patterns. In our study, aft er adjusting for patient and clinic characteristics, the main PCP predictor of CRC screening was the size of the provider ' s panel eligible for screening. PCPs that see more patients suitable for CRC screening are more likely to engage in the process. When comparing patients who were screened to those who were not, we found that screened patients were more likely to be seen by PCPs who perceive more major barriers at the system level. One explanation may be that PCPs with higher CRC screening rates can identify more system-level barriers because they are encountering them in their daily practice. However, in the fi nal multivariate logistic regression model there was no signifi cant relationship between number of perceived major barriers at the patient, provider, or system levels and patient receipt of CRC screening. Also in the fi nal multivariate model, we did not fi nd an association between CRC screening rates and PCP gender, specialty, or years in practice. In addition to patient and PCP characteristics, we identifi ed two major clinic-level factors associated with CRC screening -clinic management and distance to the nearest optical colonoscopy center. Hospital-owned clinics were more likely to screen patients for CRC than physician-owned clinics. One possible explanation is that there are stronger relationships between PCPs in these clinics with the specialists, such as gastroenterologists and radiologists who provide the majority of the screening exams. We also found that patients who received their primary care at a clinic farther away from an optical colonoscopy center had lower CRC screening rates, indicating that geographic distance may be a signifi cant barrier. However, this may be confounded by the fact that patients who are seen at more distant clinic sites are more likely to have their CRC screening exams completed at facilities outside of our system, which may not have been accurately captured in our EMR.
Our study has important implications for quality improvement interventions in CRC screening. Existing research aimed at improving CRC screening shows that single interventions tend to have small eff ects and that to achieve large, sustainable eff ects, a multipronged approach is necessary ( 43, 44 ) . Selby et al. ( 45 ) looked within a large health-care system to describe variance at the provider level for quality indicators in hypertension, hyperlipidemia, and breast cancer screening. Th ey found variation in all of these indicators and concluded that although quality improvement programs primarily targeting organized systems can be eff ective, " greater attention to understanding and reducing variability among individual physicians would be a useful additional approach for internal quality improvement eff orts. " Our results confi rm this need to understand the extent of and reasons for variation at additional levels (patient, provider, and clinic) of the health system in order to design optimal approaches for CRC screening programs.
Th ere are limitations to this study. First, we report fi ndings from a large, academic physician group, which may not be generalizable. However, large multispecialty systems are becoming a preferred way to provide high-quality health care and are increasingly recognized as critical to the understanding and improvement of health-care delivery ( 46 ) . Second, our estimates are based on EMR data, which may result in misclassifi cation of a completed screening test and may not capture individuals whose screening was done outside of our system. Th is is more likely to impact the physician-owned clinics located at a further distance from our central optical colonoscopy centers. However, all of our clinics use a fully integrated EMR that has been populated with all data from 1991, including scanned documents that are manually reviewed and added to our data set and would indicate CRC screening completion outside of UW Health. Th ird, the nearly all White patient population and overall high CRC screening rates for our health-care organization may limit the potential generalizability of our fi ndings to systems with more diverse patient populations and systems with much lower overall screening rates. Fourth, while the algorithm used to defi ne our sample population ensures that patients attributed to UW Health and a PCP have been seen in our clinical facilities at least twice in the past 3 years, there is a potential for selection bias against patients who obtain all of their care from UW Health but do not regularly utilize our health-care system. However, this is unlikely to result in a systematic bias across clinical settings. Fift h, while our defi nition 
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of CRC screening completion is consistent with a patient being considered up to date for CRC screening in the study year, it does provide a longer time frame for a patient to have completed an optical colonoscopy than for an FOBT. Also by looking back only 12 months for FOBT completion, we give the same weight to patients who have had one FOBT in the prior year as patients who have had multiple annual FOBTs in previous years. Finally, we only adjusted for a portion of the case-mix at the provider and clinic levels. A recent study published in JAMA by Hong et al. ( 47 ) investigated the relationship between patient panel characteristics and relative physician clinical performance rankings within a large academic primary-care network and found that although adjustment for patient variables may have contributed to a more accurate estimation of provider performance, it only accounted for a fraction of the total variability at the physician level. Taken together, the results of our study and the study by Hong et al. ( 47 ) leaves room to explore other potential factors that could explain the observed variation.
In conclusion, despite high overall rates of CRC screening in our health-care system, there are variations in screening rates among primary-care clinics and PCPs within a single clinic. Interventions to improve CRC screening rates will need to address the patient-, provider-, and clinic-level sources of this variation. Th e combination of multilevel factors infl uencing CRC screening will be unique to each health-care system. Our approach to examining variation in CRC screening within our system can serve as a guide for future investigations to identify reasons for screening variation in other health-care systems. 
